We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




First Endangered Species Stem Cells Generated to Create Stem-Cell Zoo

By LabMedica International staff writers
Posted on 26 Sep 2011
Starting with normal skin cells, scientists have produced the first stem cells from endangered species. More...
Such cells could eventually make it possible to improve reproduction and genetic diversity for some species, possibly saving them from extinction, or to bolster the health of endangered animals in captivity.

The study’s findings appeared in an advance online edition of the journal Nature Methods on September 4, 2011. About five years ago, Oliver Ryder, PhD, the director of genetics at the San Diego Zoo Institute for Conservation Research (CA, USA), contacted Jeanne Loring, PhD, professor of developmental neurobiology at the Scripps Research Institute (La Jolla, USA), to discuss the possibility of collecting stem cells from endangered species. Dr. Ryder’s team had already established the Frozen Zoo, a bank of skin cells and other materials from more than 800 species and wondered if the thousands of samples they had amassed might be used as starting points.

Just as is hoped with humans, Dr. Ryder believed stem cells from endangered species might enable lifesaving medical therapies or offer the potential to preserve or expand genetic diversity by offering new reproduction possibilities. At the time, although researchers were working with stem cells from embryos, scientists had not yet developed techniques for reliably inducing normal adult cells to become stem cells. But the technology arrived soon after, and scientists now accomplish this feat, called induced pluripotency, by inserting genes in normal cells that spark the transformation.

While Dr. Loring’s team met with Dr. Ryder in early 2008, they realized that these newly emerging techniques might be applied to endangered species. Postdoctoral fellow Inbar Friedrich Ben-Nun, PhD, set out to explore the possibilities systematically. Dr. Ryder suggested two species for their beginning work. The first was a highly endangered primate called a drill (Mandrillus leucophaeus) that he chose because of its close genetic connection to humans, and because in captivity the animals often suffer from diabetes, which researchers are working to treat in humans using stem cell-based therapies.

The northern white rhinoceros was the second candidate. Dr. Ryder picked this animal because it is genetically far removed from primates, and because it is one of the most endangered species in the world. There are only seven animals still in existence, two of which reside at the San Diego Zoo Safari Park.

At first, the investigators believed they would have to isolate and use genes from animals closely related to the endangered species to trigger pluripotency successfully. However, that line of research did not work. Instead, to their surprise, after a year of trial and error, the researchers found that the same genes that induce pluripotency in humans also worked for the drill and the rhino. “It has been just amazing,” remarked Dr. Ryder of the Scripps Research team’s successes.

The process is ineffective (only a few stem cells are produced at a time), but that is enough for the purpose. “There are only two animals in it,” said Dr. Ben-Nun, “but we have the start of a new zoo, the stem cell zoo.”

The scientists view their accomplishment as a first step toward greater advancements. Besides the possibility of using stem cells as the basis for diabetes or other treatments, there is great potential for new reproductive technologies as the stem cell research field advances. “The most important thing is to provide these stem cells as a resource for other people taking some of the next steps,” said Dr. Loring.

One of the greatest concerns with small populations such as the northern white rhinos (Ceratotherium simum cottoni) is that even if they did reproduce, which has not occurred in many years, their genetic diversity is inescapably, and dangerously low and such inbreeding leads to unhealthy animals.

However, researchers are moving toward inducing stem cells to differentiate into sperm or egg cells. With that accomplished, one possibility is that scientists could take skin cells in the Frozen Zoo from long dead animals, induce pluripotency, trigger differentiation into sperm cells, and then combine these with a living animal’s eggs through in vitro fertilization. Otherwise, lost genetic diversity would then be reintroduced into the population, making it healthier, larger, and more robust. Or, both eggs and sperm might be produced from the stem cells, with the resulting embryos implanted in live animals, a process that current research suggests could be much more reliable than existing cloning techniques.

Scientists are already examining the potential of producing sperm and eggs from stem cells as a possible solution to human infertility issues. Dr. Loring hopes that some of these groups might consider early technique development using endangered species stem cells. “I think that work would be a lot easier ethically with endangered species than with humans,” she said, “so I suspect some people working in this area would love to have our cells for experiments.”

“The best way to manage extinctions is to preserve species and their habitats,” stated Dr. Ryder, “but that’s not working all the time.” The rhinos are a perfect example, he said, because there are so few. “Stem cell technology provides some level of hope that they won’t have to become extinct even though they’ve been completely eliminated from their habitats. I think that if humankind wants to save this species, we're going to have to develop new methodologies.”

Moreover, even when there are reasonable wild populations of a species, they face a range of threats, including loss of habitat and poaching. Moving forward, Dr. Loring noted that the group is hoping to continue generating stem cells from other species to expand their brand-new stem cell “zoo.” For now, they are working to secure funding for what amounts to an unconventional line of research. “It’s in between fields,” said Dr. Loring. “It’s not classical conservation and it’s not ordinary biological research.”

Related Links:

San Diego Zoo Institute for Conservation Research
Scripps Research Institute






Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.